TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 842 | 2,683 | 760 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 35 | 1,995 | 537 |
EBITDA | 180 | 2,008 | 537 |
Total assets | 3,176 | 3,251 | 1,124 |
Current assets | 2,610 | 2,517 | 1,124 |
Current liabilities | 761 | 789 | 326 |
Equity capital | 2,254 | 2,297 | 775 |
- share capital | 47 | 49 | 52 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 71.0% | 70.7% | 69.0% |
Turnover per employee | 842 | 2,683 | 760 |
Profit as a percentage of turnover | 4.2% | 74.4% | 70.7% |
Return on assets (ROA) | 1.1% | 61.4% | 47.8% |
Current ratio | 343.0% | 319.0% | 344.8% |
Return on equity (ROE) | 1.6% | 86.9% | 69.3% |
Change turnover | -1,760 | 1,976 | 626 |
Change turnover % | -68% | 279% | 471% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.